Table 1 Comparison of genotype and allele frequencies of CFH, CFHR3 and CFHR5 single nucleotide polymorphisms (SNPs) in patients with rare glomerular nephropathies and control subjects.

From: A haplotype in CFH family genes confers high risk of rare glomerular nephropathies

SNP ID

 

Cases (n = 91)

Controls (n = 300)

P-value*

OR (95% CI)

CFH

 rs55807605

  Allele (%)

A

4 (2.2)

10 (1.7)

0.749

1.33 (0.41–4.28)

G

178 (97.8)

590 (98.3)

  Genotype (%)

AA

0 (0.0)

0 (0.0)

0.747a

1.33 (0.41–4.36)

AG

4 (4.4)

10 (3.3)

GG

87 (95.6)

290 (96.7)

CFHR3

 rs61737525

  Allele (%)

T

5 (2.7)

4 (0.7)

0.036

4.21 (1.12–15.84)

C

177 (97.3)

596 (99.3)

  Genotype (%)

TT

1 (1.1)

2 (0.7)

0.028a

6.85 (1.23–38.03)

TC

3 (3.3)

0 (0.0)

0.549b

1.66 (0.15–18.47)

CC

87 (95.6)

298 (99.3)

CFHR5

 rs57960694

  Allele (%)

A

4 (2.2)

4 (0.7)

0.090

3.35 (0.83–13.52)

G

178 (97.8)

596 (99.3)

  Genotype (%)

AA

0 (0.0)

0 (0.0)

0.089a

3.40 (0.83–13.89)

AG

4 (4.4)

4 (2.3)

GG

87 (95.6)

296 (97.7)

  1. n = number of subjects; OR = odds ratio; CI = confidence interval. Data shown are the number of subjects (% of the total group). *Fisher’s exact text.
  2. aP value for dominant model; bP value for recessive mode.